Thank you for donating!
You can donate using the following services.
Donate Today
Search
Need support today?
Email: info@npuk.org
Helpline: 0191 415 0693
Main menu
Niemann-Pick Disease
About Us
Care & Support
Research
Fundraising
Resources
Blog
News
NPUK Shop
COVID-19
News
NPUK
>
News
24.08.21
Orphazyme announces publication of results from its Phase 2/3 trial of arimoclomol in Niemann-Pick disease type C in the Journal of Inherited Metabolic Disease
Read more
19.08.21
IntraBio Reports Statistically Significant and Clinically Meaningful Improvements in the Use of IB1001 For Treatment of GM2 Gangliosidosis (Tay-Sachs and Sandhoff disease)
Read more
02.07.21
NPUK are hiring! (Fundraising Officer)
Read more
30.06.21
Orphazyme presents 36-month data supporting durable response to arimoclomol during Parseghian Scientific Conference for NPC Research
Read more
18.06.21
Orphazyme: NPC Community Notification
Read more
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
Next
Clinical Trials
CTD Holdings Inc
IntraBio
News
NPUK Annual Family Conference
NPUK News
Orphazyme
Sanofi Genzyme
The Quinn Madeline Foundation
Uncategorized
Vtesse
Donate today
Follow NPUK
Contact us
Donate today
Email: info@npuk.org
Helpline: 0191 415 0693